Opening the book…
After completing this chapter, you should be able to:
- Identify the people, procedures, equipment, and controls needed for a reliable laboratory quality system.
- Explain how facilities, equipment, and incoming materials support cGMP manufacturing.
- Describe how specifications and suitable test methods are established.
- Explain the investigation of an out-of-specification result and the limits on retesting.
- Distinguish calibration, verification, qualification, and validation.
- Describe the process validation life cycle and the roles of IQ, OQ, equipment PQ, and process performance qualification.
Reliable products depend on reliable laboratory results, suitable materials, controlled processes, and trained people. This workbook explains how these elements work together and how an organization investigates results that fail to meet requirements. It also distinguishes equipment qualification from the ongoing process of validation.
- 14.1: General Principles and Laboratory Management
- This page emphasizes the importance of reliable laboratory results, which should align with their intended purpose. A robust quality system, skilled personnel, and well-maintained equipment are essential, along with adherence to cGMP and ISO standards. Key elements include trained staff, clear responsibilities, and appropriate supervision. Honest reporting, including failures, is vital, and analysts should not feel pressured to modify data.
- 14.2: Facilities and Equipment in Production
- This page emphasizes the importance of quality standards in pharmaceutical facilities through rigorous contamination control and effective facility layout. It highlights key risks like contamination and mix-ups, and underscores the need for well-maintained equipment with clear status indicators. Environmental monitoring and hygiene practices must be complemented by specific sterilization protocols, particularly concerning steam exposure.
- 14.3: Handling Raw Materials and Components
- This page covers the categories and specifications for resources in pharmaceutical manufacturing, focusing on active ingredients and packaging. It emphasizes material specifications and acceptance criteria according to standards like USP–NF. The page details procedures for inspecting shipments, status controls, and quality assessments.
- 14.4: Example - Material Specification Fields
- This page details the importance of specifications in defining material and product criteria, emphasizing the need for testing based on intended use. It highlights the varying purity requirements for different grades of sodium chloride and the necessity for biomanufacturing to adhere to specific standards.
- 14.5: Establishing Specifications
- This page discusses the importance of specifications and tests for materials or products, emphasizing that intended use affects requirements, particularly for substances like sodium chloride. It highlights the need for specific evaluation criteria based on application. Establishing specifications involves defining attributes, methods, and acceptance criteria, as well as maintaining compliance. It's crucial to justify limits to uphold quality and prevent the use of unsuitable materials.
- 14.6: Processes and In Process Controls
- This page outlines the components of a process, including inputs, activities, and outputs. It stresses the significance of material attributes and operating conditions in relation to product quality during process design. Furthermore, it addresses the potential creation of waste or by-products, underscoring the importance of efficiency while maintaining consistent quality and protecting patient safety.
- 14.7: Example of a Mammalian Cell Culture Process
- This page outlines a hypothetical method for generating therapeutic proteins in a bioreactor using a recombinant mammalian cell line. It highlights vital components like qualified cell banks, culture media—favoring serum-free options—and process gases.
- 14.8: Out of Specification Results
- This page discusses the significance of out-of-specification (OOS) results, highlighting the need for thorough investigations in accordance with FDA guidelines. It emphasizes accurate categorization of lab deviations and unbiased evaluation of unusual results. Initial and full assessments review methods and broader issues, while retesting requires justification to avoid manipulating results. Documentation is crucial, and conclusions about errors should account for systemic weaknesses.
- 14.9: Change Control and Emergency Actions
- This page emphasizes the significance of change control in manufacturing, focusing on structured evaluations of changes to assess risks and impacts on product quality and safety. It highlights the necessity of departmental reviewers and thorough documentation for tracking changes and justifications. Emergency protocols are also discussed, stressing the importance of maintaining quality standards while addressing issues.
- 14.10: Designing a Controlled Manufacturing Process
- This page outlines crucial steps in product development, focusing on product definition, quality attributes, endpoint measurements, and acceptance criteria. It emphasizes the importance of robust material specifications and analytical methods, as well as developing process steps grounded in scientific studies. The need for control strategies, suitable facilities, clear responsibilities, comprehensive documentation, and training is highlighted.
- 14.11: Calibration Verification Qualification and Validation
- This page covers calibration, which aligns measurements with reference values and assesses uncertainty, distinguishing it from adjustment. It discusses calibration reports, verification for compliance checks, qualification of facilities and equipment, and validation of process suitability using scientific evidence, emphasizing that no approach guarantees absolute accuracy in all scenarios.
- 14.12: Process Validation Across the Life Cycle
- This page details the qualification processes for steam sterilizers, covering installation qualification (IQ) to verify proper setup, operational qualification (OQ) to assess functionality, and performance qualification (PQ) to evaluate operation in realistic conditions. It stresses the necessity of comprehensive documentation and outlines procedures for addressing failures in measurement instruments, including adjustments and impact evaluations.
- 14.13: Process and Analytical Method Validation
- This page discusses process validation for consistent product manufacturing, covering critical steps like mixing and sterilization. It emphasizes the importance of validating analytical procedures under FDA guidelines. Additionally, it highlights the necessary qualification of facilities and equipment, as well as the need for reliable computerized systems.
- 14.14: Example - Testing a Bioreactor Temperature Control System
- This page discusses the use of a computerized controller to monitor a bioreactor's temperature, focusing on alarm triggers, configuration recording, and testing protocols. It emphasizes the importance of defining expected alarm behaviors, handling sensor faults, and maintaining logs. Successful tests lead to the controller's implementation, but validation evidence is crucial for ensuring product quality.
- 14.15: Sterilization Validation as an Example
- This page emphasizes the importance of validating steam sterilization processes to ensure effectiveness in various conditions. It highlights the need for temperature measurement, biological indicators, and controlled challenges, as single empty chamber tests are inadequate. Factors like heat penetration and air removal within the load are crucial for successful sterilization.
- 14.16: Maintaining Control and Handling Unplanned Events
- This page emphasizes the importance of continuous monitoring of process performance following qualification and PPQ. It discusses the need for assessment when changes occur in materials or processes, which may lead to further qualification or validation. Key quality control terms such as deviation and nonconformity are highlighted, along with the necessity of thorough documentation and investigation.
- 14.17: Workplace Hazards in Biotechnology
- This page explores workplace hazards and risks, defining hazards as potential sources of harm and risks as the likelihood and severity of that harm. It stresses the importance of identifying harmful materials and exposure routes, particularly for biological and chemical hazards. Examples include aerosols and sharp objects, alongside injuries related to equipment and ergonomic issues.
- 14.18: Choosing and Checking Exposure Controls
- This page discusses the hierarchy of controls for reducing hazard exposure, emphasizing methods like elimination and PPE. It illustrates a technician managing centrifuge tasks, selecting safe practices with the help of EHS staff. The page highlights the importance of reviewing risks before implementing changes to confirm the effectiveness of safety measures, which must be verified by supervisors.
- 14.19: Mock Audit of Sample Receiving
- This page outlines the internal audit process for sample receiving procedures, detailing steps for planning, evidence gathering, and documentation of findings, including adherence to key acceptance criteria. It addresses assigning roles, using checklists, interviewing staff, and noting non-compliance issues. The audit concludes with a verification of corrective actions and their effectiveness.
- 14.20: Chapter Summary
- This page covers the components of a connected quality system in laboratories, highlighting the significance of skilled personnel, defined responsibilities, and controlled processes for reliable outcomes. It differentiates between calibration, verification, qualification, and validation, and outlines the process validation life cycle with a focus on ongoing verification for maintaining product quality and ensuring patient safety.
This page titled 14: Quality Systems in the Laboratory and Production Facility was last modified on Thu, 05 Nov 2026 13:00:30 GMT and is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by Emalee MacKenzie.
The book could not be loaded just now.